Refine by
Biomarker Identification Articles & Analysis
16 news found
By leveraging its expertise in assay development, biomarker identification, and regulatory compliance, Protheragen aims to advance rare disease diagnostics and accelerate the path from diagnostic research to commercialization. ...
It provides customers with comprehensive solutions including instruments, consumables, reagents, and software for the analysis of gene loci related to birth defect prevention and control, drug genomes, tumours, infectious diseases, and other fields.GETOTEC, a fully-automated capillary electrophoresis instrument, ClinCap 1000, with independent intellectual property rights under FPI Life Sciences, ...
The product manager is pleased to announce the launch of its Microbial Biomarker Discovery service, a revolutionary solution that promises to transform microbiology research. ...
Based on rich experience in genomic analysis, CD Genomics has developed a specialized platform for targeted sequencing of cancer-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. The company has optimized its Cancer Hotspot Panel Sequencing service to meet the most ...
The device can transmit the data on cardiac hemodynamic parameters to clinicians through cellular networks, and uses AI-based algorithms to identify a variety of hemodynamic biomarkers to aid in early identification and diagnosis. The system also incorporates a digital dashboard that lets healthcare staff to easily view trends in a patient’s data over time. ...
The paper entitled, “A multimodal biomarker for concussion identification, prognosis and management" describes a study which enrolled 568 concussed and matched control patients between the ages of 13-25. Results from this study demonstrated highly significant differences in the BrainScope EEG-based biomarker at the time of injury between ...
Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment. ...
In the study, the Cellworks Biosimulation Platform and CBM was used to assess cytarabine (ARA-C) and anthracycline response and novel biomarker response criteria for the addition of etoposide (VP16) in AML. ...
“Ideally, patients predicted to be non-responders could be offered to participate in a clinical trial for a new therapy or combination treatment where they were predicted to have a higher likelihood of response based on their genetic biomarkers. By using Cellworks MDS biomarker identifications and therapy response predictions in advance of ...
Integration analysis of multiple sequencing data provides a broader view of the genomics research, which comes extremely handy in gene expression and regulation analysis, biomarker identification, bio-interaction analysis, and more. Based on advanced sequencing technology and an experienced team of scientists, CD Genomics provides high-quality integration ...
Transcriptomics enables genome-wide analysis of transcription at single-nucleotide resolution, including determination of the relative abundance of transcripts, unbiased identification of alternative splicing events and post-transcriptional RNA editing events, and detection of single nucleotide polymorphisms (SNPs). ...
Lung cancer is the leading cause of cancer deaths worldwide.1 EGFR mutations are an important therapeutic target in NSCLC; EGFR Exon20 insertion mutations, specifically, are associated with resistance to immune checkpoint inhibitor therapies and poor patient prognosis.2 Further, EGFR Exon20 insertion mutations are often under-detected by conventional, single-gene testing methods.4,5 This is ...
The product manager has recently announced the fully-developed exosomes lipidomics service to help identify lipid-based biomarkers and unravel its monitoring function in diseases. Exosomes are considered to be a new and effective intercellular communication carrier. ...
Thermo Fisher Scientific, the world leader in serving science, and Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, have entered into a collaborative partnership to advance the early diagnosis of cancer and other diseases through the discovery and validation of novel biomarkers by non-invasive breath sampling. Through the ...
Published in the peer-reviewed journal Computers in Biology and Medicine, the paper entitled, “A multimodal biomarker for concussion identification, prognosis and management" describes a study which enrolled 568 concussed and matched control patients between the ages of 13-25 from 29 colleges and 19 high schools. ...
BioSystem Development's AssayMAP platform, based on disposable microchromatography cartridges, enables high-throughput protein purification, characterization and analysis solutions for bioprocess development, biomarker identification and analysis, as well as a variety of other life science research applications. ...